| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/16/2002 | EP1172102A2 Combination of 3-iodo-2-propynyl-butylcarbamate esters and one or more hydroxybenzoic acids and phenoxyethanol |
| 01/16/2002 | EP1171629A1 Novel essential bacterial genes and their proteins |
| 01/16/2002 | EP1171626A1 50 human secreted proteins |
| 01/16/2002 | EP1171623A2 Production of attenuated negative stranded rna virus vaccines |
| 01/16/2002 | EP1171608A2 Recombinant and mutant marek's disease virus |
| 01/16/2002 | EP1171599A1 Adipocyte complement related protein homolog zacrp2 |
| 01/16/2002 | EP1171596A1 Synthetic transmembrane components |
| 01/16/2002 | EP1171591A1 48 human secreted proteins |
| 01/16/2002 | EP1171590A1 50 human secreted proteins |
| 01/16/2002 | EP1171586A2 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 01/16/2002 | EP1171583A2 A multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides |
| 01/16/2002 | EP1171579A1 Human tumor necrosis factor receptor tr9 |
| 01/16/2002 | EP1171578A2 Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof |
| 01/16/2002 | EP1171577A2 Anti-bacterial vaccine compositions |
| 01/16/2002 | EP1171576A1 PSEUDOMYCIN PRODUCTION BY $i(PSEUDOMONAS SYRINGAE) |
| 01/16/2002 | EP1171463A2 Peptide homodimers and peptide heterodimers, derived from interferon alpha 2 |
| 01/16/2002 | EP1171462A2 49 human secreted proteins |
| 01/16/2002 | EP1171457A1 46 human secreted proteins |
| 01/16/2002 | EP1171448A2 Macrolide antiinfective agents |
| 01/16/2002 | EP1171447A2 Ketolide antibacterials |
| 01/16/2002 | EP1171446A2 Macrolide antiinfective agents |
| 01/16/2002 | EP1171442A1 Xanthine derivatives and analogs as cell signalling inhibitors |
| 01/16/2002 | EP1171435A2 Pyrimidine-2-one derivatives as integrin receptor ligands |
| 01/16/2002 | EP1171428A1 Fab i inhibitors |
| 01/16/2002 | EP1171424A1 Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
| 01/16/2002 | EP1171422A1 Mmp inhibitor |
| 01/16/2002 | EP1171176A1 Implant for recreating verterbrae and tubular bones |
| 01/16/2002 | EP1171175A1 Endoprosthesis with long-term stability |
| 01/16/2002 | EP1171160A1 Method and means for treating post-polio syndrome |
| 01/16/2002 | EP1171159A2 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv) |
| 01/16/2002 | EP1171158A2 Vaccine comprising rsv antigen and cpg oligonucleotide |
| 01/16/2002 | EP1171154A2 Uses of mammalian ox2 protein and related reagents |
| 01/16/2002 | EP1171152A1 vMIP-II PEPTIDE ANTAGONISTS OF CXCR4 |
| 01/16/2002 | EP1171150A2 Pseudomycin antifungal compositions and methods for their use |
| 01/16/2002 | EP1171136A2 Immunomodulating composition for use especially in the treatment of inflammations, infections and surgical adhesions |
| 01/16/2002 | EP1171130A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same |
| 01/16/2002 | EP1171127A2 Pharmaceutical compositions containing pyridine or pyrimidine derivatives for inhibition of cytokine production and secretion |
| 01/16/2002 | EP1171122A1 Pyrrolidine modulators of chemokine receptor activity |
| 01/16/2002 | EP1171102A1 Anhydrous tablet of ranitidine hydrochloride with double-layer coating and its composition |
| 01/16/2002 | EP1171098A1 A method for improving the half-life of soluble viral-specific ligands on mucosal membranes |
| 01/16/2002 | EP1171093A2 Skin care compositions containing combination of skin care actives |
| 01/16/2002 | EP1171081A2 Skin care compositions containing combination of skin care actives |
| 01/16/2002 | EP1082012A4 Novel nucleosides having bicyclic sugar moiety |
| 01/16/2002 | EP0811071B1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins |
| 01/16/2002 | EP0697875B1 Use of modified tall-104 cells to treat cancer and viral diseases |
| 01/16/2002 | EP0603386B1 Parenteral immunization against rotavirus |
| 01/16/2002 | CN1331801A Kidney disease detection and treatment |
| 01/16/2002 | CN1331701A Modified peptides as therapeutic agents |
| 01/16/2002 | CN1331699A Methods of identifying antigen gene sequences |
| 01/16/2002 | CN1331695A Organo-phosphorus compounds and their utilization |
| 01/16/2002 | CN1331691A Piperidines as CCR5 modulators |
| 01/16/2002 | CN1331688A Aminopyrazole derivatives |
| 01/16/2002 | CN1331683A 2-phenylbenzimidazoles and 2-phenylindoles, and prodn. and use thereof |
| 01/16/2002 | CN1331604A Compsn. consisting of influenza virus surface proteins and dispensing device |
| 01/16/2002 | CN1331597A Use of bisphosphonates for prevention and treatment of infectious processes |
| 01/16/2002 | CN1331593A Pharmaceutical compsns. contg. tetrahydroisoquinoline compounds |
| 01/16/2002 | CN1331591A Piperidines as CCR5 modulators |
| 01/16/2002 | CN1331558A Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
| 01/16/2002 | CN1331250A Glucoprotein having inhibitory activity to pyroric spirillar colonization |
| 01/16/2002 | CN1330946A Process for preparing garlic injection |
| 01/16/2002 | CN1330945A Medicine for treating cold in any season and its product |
| 01/16/2002 | CN1330942A Chinese patent medicine for treating pulmonary tuberculosis |
| 01/16/2002 | CN1330923A Medicine for treating foot ringwoorm |
| 01/16/2002 | CN1330922A Medicinal composition for treating or preventing diseases associated with immunodeficiency virus and reverse transcription virus |
| 01/16/2002 | CN1077886C Amidino derivatives useful as nitric oxide synthase inhibitors |
| 01/16/2002 | CN1077799C prevention of retinal injury and degeneration by specfic factors |
| 01/15/2002 | US6339073 Uses of nicotinamide adenine dinucleotide and its derivatives for treatment of malignant and infectious diseases |
| 01/15/2002 | US6339069 Administering formulation comprising pharmaceutically acceptable carrier; and, liposome comprising a bioactive agent and a lipid component, the lipid component comprising a peptide-lipid conjugate |
| 01/15/2002 | US6338844 Genomic nucleic acids, cDNA and mRNA which code for polypeptides with IL-16 activity, processes for the production thereof and their use |
| 01/15/2002 | CA2121604C Diagnosis and treatment of bacterial dysentery |
| 01/15/2002 | CA2001719C Phosphorylated fusion proteins and uses related thereto |
| 01/10/2002 | WO2002002781A1 Heterodimeric fusion proteins |
| 01/10/2002 | WO2002002755A2 Regulation of human thimet oligopeptidase-like enzyme |
| 01/10/2002 | WO2002002634A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/10/2002 | WO2002002633A2 Transporters and ion channels |
| 01/10/2002 | WO2002002629A2 Grf2-binding proteins and applications thereof |
| 01/10/2002 | WO2002002619A1 The t-cell protein (tzon7), peptides and antibodies derived therefrom and uses thereof |
| 01/10/2002 | WO2002002607A2 Acid-modified arabinogalactan protein composition |
| 01/10/2002 | WO2002002606A2 Immunisation against chlamydia pneumoniae |
| 01/10/2002 | WO2002002603A2 Protein modification and maintenance molecules |
| 01/10/2002 | WO2002002595A1 Amphipathic linear peptides and compositions containing same |
| 01/10/2002 | WO2002002588A1 Sugar chain-containing carbosilane dendrimer compounds, process for producing the same and verotoxin neutralizers and antiviral agents |
| 01/10/2002 | WO2002002587A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | WO2002002584A1 Base analogues |
| 01/10/2002 | WO2002002566A1 Therapeutic compounds and methods |
| 01/10/2002 | WO2002002558A1 Pyrroloquinolones as antiviral agents |
| 01/10/2002 | WO2002002554A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 01/10/2002 | WO2002002525A2 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
| 01/10/2002 | WO2002002524A1 Pyrrole derivatives for treating aids |
| 01/10/2002 | WO2002002511A1 Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness |
| 01/10/2002 | WO2002002142A1 Papillomavirus vaccine |
| 01/10/2002 | WO2002002141A2 Vaccine against helicobacter pylori |
| 01/10/2002 | WO2002002139A2 Methods and composition for oral vaccination |
| 01/10/2002 | WO2002002138A1 Treating endotoxemia and related disorders with probiotics |
| 01/10/2002 | WO2002002132A1 Chemokine conjugates |
| 01/10/2002 | WO2002002131A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/10/2002 | WO2002002128A2 Oral compositions comprising antimicrobial agents |
| 01/10/2002 | WO2002002121A2 Method for treatment and prevention of mastitis |
| 01/10/2002 | WO2002002118A1 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies |
| 01/10/2002 | WO2002002105A1 Therapeutic combinations of fatty acids |